Spots Global Cancer Trial Database for cancer of breast
Every month we try and update this database with for cancer of breast cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC | NCT05191004 | Advanced Breast... Metastatic Brea... Breast Cancer Breast Carcinom... Cancer of the B... Cancer of Breas... Malignant Tumor... Breast Tumor | NUV-422 Fulvestrant | 18 Years - | Nuvation Bio Inc. | |
| Shave Margins in Breast Conservation Therapy | NCT02462200 | Breast Cancer Cancer of Breas... Cancer of the B... | Breast-conservi... Cavity shave ma... BREAST-Q Questi... 3-D breast imag... Indocyanine gre... Intraoperative ... Peripheral bloo... | 18 Years - 85 Years | Washington University School of Medicine | |
| A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer | NCT05584644 | Breast Cancer Breast Carcinom... Breast Neoplasm... Breast Tumors Cancer of Breas... | Palbociclib plu... Palbociclib plu... | 18 Years - 99 Years | Pfizer | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial | NCT00872859 | Breast Cancer Reconstructive ... | Implantation of... | 18 Years - 80 Years | University of Utah | |
| Aging Mammary Stem Cells and Breast Cancer Prevention | NCT02642094 | Cancer of Breas... | Rapamycin | 18 Years - 80 Years | The University of Texas Health Science Center at San Antonio | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer | NCT00065325 | Locally Advance... Metastatic Brea... | Fulvestrant Exemestane | 32 Years - 91 Years | AstraZeneca | |
| Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment | NCT01596530 | Breast Neoplasm | Drug-AZD8931 Drug-Placebo | 18 Years - | AstraZeneca | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | NCT02316795 | Breast Cancer Cancer of Breas... Cancer of the B... Melanoma Malignant Melan... | Sentinel lymph ... Goggle-based de... Indocynanine Gr... | 18 Years - | Washington University School of Medicine | |
| Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer | NCT01271738 | Breast Neoplasm... Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Human Mammary C... Neoplasms, Brea... | Remove tumor on... Removal of tumo... | 18 Years - | Emory University | |
| A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer | NCT01265927 | Breast Neoplasm... | GRN163L in comb... | 18 Years - | Indiana University | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| Bright Light on Fatigue in Women Being Treated for Breast Cancer | NCT02658708 | Breast Neoplasm... Breast Cancer Cancer of Breas... Cancer of the B... | Bright blue-gre... Dim red light u... European Organi... Epworth Sleepin... Pittsburgh Slee... Patient-Reporte... Patient-Reporte... Digital foot ca... Polysomnography... Horne-Ostberg M... Daily Fatigue a... | 21 Years - | Washington University School of Medicine | |
| Aging Mammary Stem Cells and Breast Cancer Prevention | NCT02642094 | Cancer of Breas... | Rapamycin | 18 Years - 80 Years | The University of Texas Health Science Center at San Antonio | |
| A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | NCT00091442 | Breast Cancer | Docetaxel DOXIL | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer | NCT00983684 | Invasive Breast... Breast Cancer | Intrabeam Post-operative ... | 45 Years - | University College, London | |
| Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients | NCT04400552 | Cancer of Breas... Cancer Colon | ONS Pre-op + ON... ONS Pre-op + ON... Usual intake Pr... | 25 Years - 65 Years | International Medical University | |
| Change in Cardiorespiratory Fitness and Breast Cancer Incidence and Mortality | NCT05729451 | Cancer of Breas... Cardiorespirato... Occupational He... | 18 Years - | The Swedish School of Sport and Health Sciences | ||
| Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer | NCT02907918 | Breast Cancer Cancer of Breas... Breast Carcinom... | Palbociclib Letrozole Trastuzumab Goserelin Breast surgery Research tumor ... Research bone m... Research blood ... Research blood ... Blood for detec... | 18 Years - | Washington University School of Medicine | |
| PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery | NCT03084536 | Breast Cancer Breast Cancer F... Cancer of Breas... | Bupivacaine Gabapentin Celecoxib Acetaminophen Midazolam Fentanyl | 18 Years - | Washington University School of Medicine | |
| Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment | NCT02891681 | Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Malignant Neopl... | Optical Tomogra... | 18 Years - | Washington University School of Medicine | |
| Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer | NCT03007979 | Breast Cancer Breast Carcinom... Cancer of Breas... Malignant Tumor... | Palbociclib Letrozole Fulvestrant Optional resear... Goserelin Research blood ... Circulating tum... Tumor biopsy (o... | 18 Years - | Washington University School of Medicine | |
| Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer | NCT03511378 | Breast Cancer | Lupin's Pegfilg... Neulasta® | 18 Years - | Lupin Ltd. | |
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC | NCT05191004 | Advanced Breast... Metastatic Brea... Breast Cancer Breast Carcinom... Cancer of the B... Cancer of Breas... Malignant Tumor... Breast Tumor | NUV-422 Fulvestrant | 18 Years - | Nuvation Bio Inc. | |
| Single Dose Partial Breast Radiotherapy | NCT00944528 | Breast Cancer | Radiosurgery | 55 Years - 80 Years | Duke University | |
| Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer | NCT01980823 | Breast Cancer Breast Tumors Cancer of Breas... | Metformin Atorvastatin Breast surgery | 21 Years - | Columbia University | |
| Therapeutic Dose Monitoring (TDM) of Tamoxifen | NCT05133674 | Breast Cancer Breast Carcinom... Breast Tumors Cancer of Breas... Malignant Neopl... | Tamoxifen 20 mg | 18 Years - | Karolinska University Hospital | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Change in Cardiorespiratory Fitness and Breast Cancer Incidence and Mortality | NCT05729451 | Cancer of Breas... Cardiorespirato... Occupational He... | 18 Years - | The Swedish School of Sport and Health Sciences | ||
| The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial | NCT00872859 | Breast Cancer Reconstructive ... | Implantation of... | 18 Years - 80 Years | University of Utah | |
| Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | NCT00063570 | Breast Cancer Breast Neoplasm... | Pemetrexed Gemcitabine Gemcitabine Pemetrexed | 18 Years - | Eli Lilly and Company | |
| CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study | NCT00412412 | Breast Cancer | CNF2024 CNF2024 + trast... | 18 Years - | Biogen | |
| Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | NCT02316795 | Breast Cancer Cancer of Breas... Cancer of the B... Melanoma Malignant Melan... | Sentinel lymph ... Goggle-based de... Indocynanine Gr... | 18 Years - | Washington University School of Medicine | |
| A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer | NCT05584644 | Breast Cancer Breast Carcinom... Breast Neoplasm... Breast Tumors Cancer of Breas... | Palbociclib plu... Palbociclib plu... | 18 Years - 99 Years | Pfizer | |
| PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery | NCT03084536 | Breast Cancer Breast Cancer F... Cancer of Breas... | Bupivacaine Gabapentin Celecoxib Acetaminophen Midazolam Fentanyl | 18 Years - | Washington University School of Medicine | |
| Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | NCT02225470 | HER2-Negative B... Triple Negative... Breast Cancer Cancer of Breas... Breast Tumors | E7389 (Eribulin... Vinorelbine inj... | 18 Years - 70 Years | Eisai Inc. | |
| Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer | NCT01271738 | Breast Neoplasm... Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Human Mammary C... Neoplasms, Brea... | Remove tumor on... Removal of tumo... | 18 Years - | Emory University | |
| Aerobic Training in Treatment for Breast Cancer | NCT03494400 | Cancer of Breas... Healthy | Aerobic Trainin... Aerobic Trainin... | 18 Years - | Universidade Estadual Paulista Júlio de Mesquita Filho | |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer | NCT00065325 | Locally Advance... Metastatic Brea... | Fulvestrant Exemestane | 32 Years - 91 Years | AstraZeneca | |
| MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer | NCT03285607 | Breast Cancer Cancer of Breas... | MCS110 Doxorubicin Cyclophosphamid... Paclitaxel Bone marrow asp... Peripheral bloo... Tumor tissue | 18 Years - | Washington University School of Medicine | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment | NCT02891681 | Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Malignant Neopl... | Optical Tomogra... | 18 Years - | Washington University School of Medicine | |
| Telehealth Weight Loss Program for Breast Cancer Survivors | NCT04855552 | Cancer Survivor... Cancer of Breas... Body Weight Overweight and ... | Behavioral Weig... Behavioral Weig... Validated Surve... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | NCT00063570 | Breast Cancer Breast Neoplasm... | Pemetrexed Gemcitabine Gemcitabine Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors | NCT02611544 | Breast Neoplasm... Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear Neoplasm Remiss... Spontaneous Neo... Regression, Spo... Remission, Spon... Spontaneous Neo... | Acceptance and ... Survivorship Ed... Enhanced Usual ... | 18 Years - 99 Years | Indiana University | |
| Cancer Pain Management Using a Web-based Intervention | NCT06085313 | Cancer of Breas... Depressive Symp... Cancer Pain | CAI CAPA | 18 Years - | University of Texas at Austin | |
| Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | NCT02225470 | HER2-Negative B... Triple Negative... Breast Cancer Cancer of Breas... Breast Tumors | E7389 (Eribulin... Vinorelbine inj... | 18 Years - 70 Years | Eisai Inc. | |
| Cancer Pain Management Using a Web-based Intervention | NCT06085313 | Cancer of Breas... Depressive Symp... Cancer Pain | CAI CAPA | 18 Years - | University of Texas at Austin | |
| Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI | NCT02375048 | Cancer of Breas... | Hypofractionate... Accelerated Par... | 55 Years - 70 Years | Istituto Clinico Humanitas | |
| A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | NCT00091442 | Breast Cancer | Docetaxel DOXIL | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors | NCT02611544 | Breast Neoplasm... Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear Neoplasm Remiss... Spontaneous Neo... Regression, Spo... Remission, Spon... Spontaneous Neo... | Acceptance and ... Survivorship Ed... Enhanced Usual ... | 18 Years - 99 Years | Indiana University | |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer | NCT00065325 | Locally Advance... Metastatic Brea... | Fulvestrant Exemestane | 32 Years - 91 Years | AstraZeneca | |
| A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer | NCT00320541 | Breast Cancer | gemcitabine paclitaxel bevacizumab | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
